Malaysia vs Peru: The number of people with susceptibility test result for rifampicin
Malaysia
10,434
in 2021
Peru
13,453
in 2021
Malaysia rank
20th
Peru rank
18th
The number of people with susceptibility test result for rifampicin over time
- Malaysia
- Peru
How they compare
Peru currently reports 13,453 against 10,434 in Malaysia, a difference of 3,019.
That makes Peru's figure about 1.3 times Malaysia's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Peru ahead.
Malaysia ranks 20th and Peru ranks 18th of 155 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malaysia | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11,620 | 13,485 | 1,866 | Peru |
| 2020s | 10,381 | 11,518 | 1,137 | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malaysia or Peru?
- Peru, at 13,453 against 10,434 in Malaysia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malaysia and Peru?
- 3,019, with Peru ahead.
- How many years of comparable data are there for Malaysia and Peru?
- 5 years are reported by both, from 2017 to 2021.
- How do Malaysia and Peru rank globally for the number of people with susceptibility test result for rifampicin?
- Malaysia ranks 20th and Peru ranks 18th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.